MATTHEW NEBRIJA: Open Payments
NPI 1710766431 · PORT JEFFERSON STATION, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,004 in 43 payments from 17 companies in 2025. Trend: 2023 $134 · 2024 $192 · 2025 $1,004
Food & beverage: $1,004
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 16 | $343 |
| GlaxoSmithKline, LLC. | 6 | $176 |
| Smith+Nephew, Inc. | 1 | $59 |
| CSL Behring | 3 | $59 |
| Grifols USA, LLC | 2 | $54 |
| Paratek Pharmaceuticals, Inc. | 3 | $50 |
| PFIZER INC. | 2 | $38 |
| Genentech USA, Inc. | 1 | $31 |
| Integra LifeSciences Corporation | 1 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
Products named: DUPIXENT, NUCALA, TULA, Hizentra, XOLAIR, Xembify, XHANCE, OCTAGAM IMMUNE GLOBULIN (HUMAN).
Industry payments across NY — which companies pay providers there.
